Loading clinical trials...
Loading clinical trials...
Difficulties with speech and language are the first and most notable symptoms of primary progressive aphasia (PPA). While there is evidence that demonstrates positive effects of speech-language treatm...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Texas at Austin
Collaborators
NCT05592678 · Alzheimer's Disease (AD), Dementia, and more
NCT04896775 · Insomnia, Dementia
NCT06051123 · ALSFTD, ALS (Amyotrophic Lateral Sclerosis), and more
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease
University of Texas at Austin
Austin, Texas
Hospital de la Santa Creu i Sant Pau
Barcelona
Hospital Clínic de Barcelona
Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions